Development of self-assembled nanoceramic carrier construct(s) for vaccine delivery

Journal of Biomaterials Applications

Volumn 24, Issue 1, 2009, Pages 65-84

  Goyal, Amit K ^a,b   Khatri, Kapil ^a   Mishra, Neeraj ^a   Mehta, Abhinav ^a   Vaidya, Bhuvaneshwar ^a,b   Tiwari, Shailja ^a   Paliwal, Rishi ^a,b   Paliwal, Shivani ^a,b   Vyas, Suresh P ^a,b  

^a DR H S GOUR UNIVERSITY   (India)

^b ISF COLLEGE OF PHARMACY   (India)

Author keywords

Drug delivery; Hydroxyapatite; Malaria; Nanoparticles; Vaccines

Indexed keywords

ADSORPTION EFFICIENCY; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELLS; BIODEGRABILITY; COPRECIPITATION METHOD; CRYSTALLINITY; CYTOTOXIC; IMMUNOADJUVANT; IMMUNOGENS; IMMUNOGLOBULIN G; IMMUNOLOGICAL REACTIONS; IN-VITRO; LARGE SURFACE AREA; LOADING EFFICIENCY; MALARIA; MEROZOITE SURFACE PROTEINS; NANO CERAMICS; NONVIRAL; PHYSICOCHEMICAL PROPERTY; SCAFFOLDS FOR TISSUE ENGINEERING; SELF-ASSEMBLED; SMALL SIZE; SPLEEN CELLS; VACCINE DELIVERY;

ADSORPTION; ANTIGENS; APATITE; BIOMATERIALS; DRUG DELIVERY; GENE TRANSFER; HYDROXYAPATITE; NANOPARTICLES; PRECIPITATION (CHEMICAL); SINTERING; SULFATE MINERALS; TISSUE ENGINEERING; VACCINES;

HYDROXYLATION;

ALUMINUM POTASSIUM SULFATE; ALUMINUM SULFATE; DRUG CARRIER; HYDROXYAPATITE; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; MALARIA VACCINE; MANNOSE; MEROZOITE SURFACE PROTEIN 1; NANOPARTICLE;

ADSORPTION; ANIMAL; ANTIBODY PRODUCTION; ARTICLE; BAGG ALBINO MOUSE; CHEMISTRY; FEMALE; IMMUNOLOGY; MOUSE; PLASMODIUM; TH1 CELL; TH2 CELL; ULTRASTRUCTURE;

ADJUVANTS, IMMUNOLOGIC; ADSORPTION; ALUM COMPOUNDS; ANIMALS; ANTIBODY FORMATION; DRUG CARRIERS; DURAPATITE; FEMALE; IMMUNOGLOBULIN G; MALARIA VACCINES; MANNOSE; MEROZOITE SURFACE PROTEIN 1; MICE; MICE, INBRED BALB C; NANOPARTICLES; PLASMODIUM; TH1 CELLS; TH2 CELLS;

EID: 67650168749     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328209104018     Document Type: Article

References (22)

1. Storni, T., Kundig, T.M., Senti, G. and Johansen, P. (2005). Immunity in Response to Particulate Antigen-delivery Systems, Adv. Drug Del. Rev., 57: 333-355.
2. Brennan, F.R. and Dougan, G. (2005). Non-clinical Safety Evaluation of Novel Vaccines and Adjuvants: New Products, New Strategies, Vaccine, 23: 3210-3222.
3. O'Hagan, D.T., MacKichan, M.L. and Singh, M. (2001). Recent Developments in Adjuvants for Vaccines Against Infectious Diseases, Biomol. Eng., 18: 69-85.
4. Olton, D., Li, J., Wilson, M.E., Rogers, T., Close, J., Huang, L., Kumta, P.N. and Sfeir, C. (2007). Nanostructured Calcium Phosphates (NanoCaPs) for Non-viral Gene Delivery: Influence of the Synthesis Parameters on Transfection Efficiency, Biomaterials, 28: 1267-1279.
5. Doonan, S. (2004). Chromatography on Hydroxyapatite, Methods Mol. Biol., 244: 191-194.
6. Ueno, Y., Futagawa, H., Takagi, Y., Ueno, A. and Mizushim, Y. (2005). Drug-incorporating Calcium Carbonate Nanoparticles for a New Delivery System, J. Control Rel., 103: 93-98.
7. Wassell, D.T.H., Hall, R.C. and Embery, G. (1995). Adsorption of BSA onto Hydroxyapatite, Biomaterials, 16: 697-702.
8. Kandori, K., Miyagawa, K. and Ishikawa, T. (2004). Adsorption of Gamma Immuno Globulin onto Various Synthetic Calcium Hydroxyapatite Particles, J. Colloid Interf. Sci., 273: 406-413.
9. Matsumoto, T., Okazaki, M., Inoue, M., Yamaguchi, S., Kusunose, T., Toyonaga, T., Hamada, Y. and Takahashi, J. (2004). Hydroxyapatite Particles as a Controlled Release Carrier of Protein, Biomaterials, 25: 3807-3812.
10. Luo, Q. and Andrade, J.D. (1998). Cooperative Adsorption of Proteins onto Hydroxyapatite, J. Colloid Interf. Sci., 200: 104-113.
11. Gorbunoff, M.J. (1984). The Interaction of Proteins with Hydroxyapatite, Anal. Biochem., 136: 425-432.
12. Paul, W. and Sharma, C.P. (2003). Ceramic Drug Delivery: A Perspective, J. Biomater. Appl., 17: 253-264.
13. Lindblad, E.B. (2004). Aluminium Compounds for use in Vaccines, Immunol. Cell Biol., 82: 497-505.
14. Gupta, R.K., Rost, B.E., Relyveld, E. and Siber, G.R. (1995). Adjuvant Properties of Aluminum and Calcium Compounds, In: Powell, M.F. and Newman, M.J. (eds), Vaccine Design: The Subunit and Adjuvant Approach, pp. 229-248, Plenum Press, New York.
15. Pham, H.N., Luo, P., Genin, F. and Dash, A.K. (2002). Synthesis and Characterization of Hydroxyapatite-ciprofloxacin Delivery Systems by Precipitation and Spray Drying Technique, AAPS Pharm. Sci. Tech., 3: E1-E7.
16. Tas, A.C. (2001). X-ray Diffraction Data for Flux Grown Calcium Hydroxyapatite Whiskers, Powder Diffr., 16: 102-106.
17. Mizushima, Y., Ikoma, T., Tanaka, J., Hoshi, K., Ishihara, T., Ogawa, Y. and Ueno, A. (2006). Injectable Porous Hydroxyapatite Microparticles as a New Carrier for Protein and Lipophilic Drugs, J. Control Rel., 110: 260-265.
18. Dias, A.G., Lopes, M.A. and Santos, J.D. (2006). In Vivo Performance of Biodegradable Calcium Phosphate Glass Ceramics using the Rabbit Model: Histological and Sem Observation, J. Biomater. Appl., 20: 253-266.
19. Sachdeva, S., Ahmad, G., Malhotra, P., Mukherjee, P. and Chauhan, V.S. (2004). Comparison of Immunogenicities of Recombinant Plasmodium Vivax Merozoite Surface Protein 119 and 42 kilodalton Fragments Expressed in Escherichia coli, Infect. Immun., 70(10): 5775-5785.
20. Saifuddin, M., Hart, M.L., Gewurz, H., Zhang, Y. and Spear, G.T. (2000). Interaction of Mannose-binding Lectin with Primary Isolates of Human Immunodeficiency Virus Type 1, J. Gen. Virol., 81: 949-955.
21. Hegde, V.L. and Venkatesh, Y.P. (2007). Generation of Antibodies Specific to D-mannitol, a Unique Haptenic Allergen, using Reductively Aminated D-mannose-bovine Serum Albumin Conjugate as the Immunogen Immunobiol, 212: 119-128.
22. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y., Pulendran, B. and Palucka, K. (2000). Immunobiology of Dendritic Cells, Annu. Rev. Immunol., 8: 767-811.